SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 53 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $257,000 | -62.5% | 295,613 | 0.0% | 0.11% | -72.4% |
| Q1 2019 | $686,000 | 0.0% | 295,613 | 0.0% | 0.40% | -10.9% |
| Q4 2018 | $686,000 | -84.3% | 295,613 | 0.0% | 0.45% | -86.7% |
| Q3 2018 | $4,381,000 | -2.4% | 295,613 | 0.0% | 3.38% | -1.6% |
| Q2 2018 | $4,490,000 | -19.1% | 295,613 | 0.0% | 3.44% | -25.0% |
| Q1 2018 | $5,552,000 | – | 295,613 | – | 4.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 758,610 | $11,523,000 | 8.50% |
| Wildcat Capital Management, LLC | 295,613 | $4,490,000 | 3.44% |
| Cohen Capital Management, Inc. | 115,420 | $1,753,000 | 0.41% |
| CLOUGH CAPITAL PARTNERS L P | 292,695 | $4,446,000 | 0.40% |
| PFM Health Sciences, LP | 1,551,293 | $23,564,000 | 0.37% |
| Asymmetry Capital Management, L.P. | 24,516 | $372,000 | 0.37% |
| Partner Investment Management, L.P. | 17,343 | $263,000 | 0.21% |
| IFP Advisors, Inc | 180,552 | $2,743,000 | 0.12% |
| TIVERTON ASSET MANAGEMENT LLC | 78,031 | $1,185,000 | 0.06% |
| Artal Group S.A. | 99,000 | $1,504,000 | 0.03% |